To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Assessment of 2-year outcome between calcium phosphate-hybridized vs untreated STG autograft in ACLR

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2019

Assessment of 2-year outcome between calcium phosphate-hybridized vs untreated STG autograft in ACLR

Vol: 8| Issue: 3| Number:6| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Anatomic single-bundle anterior cruciate ligament reconstruction using a calcium phosphate-hybridized tendon graft: a randomized controlled trial with 2 years of follow-up

J Orthop Surg Res. 2018 Dec 29;13(1):327. doi: 10.1186/s13018-018-1045-1

Contributing Authors:
H Mutsuzaki T Kinugasa K Ikeda M Sakane

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

90 patients scheduled for anterior cruciate ligament reconstruction with a hamstring autograft were randomized to either have the ends of the graft treated with calcium chloride and sodium phosphate solutions for calcium phosphate hybridization (CaP group), or to no treatment of the graft. Patients were assessed on CT scans for increase in cross-sectional area of the femoral and tibial bone tunnel...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.